Ailte I, Chauhan SK, Prasmickaite L, Bassarova AV, Poissonnier A, Feenstra M, Nyakas M, Johannessen B, Ryder T, Hermann R, Frich L, Holth A, Inderberg EM, Jespersen H, Flørenes VA, Kyte JA, Mælandsmo GM, Egeland EV (2026)
CD38^hiCD19^dim cells in lymph nodes predict favorable prognosis in patients with stage III melanoma receiving adjuvant PD-1-blockade
Front Oncol, 16, 1815008
DOI 10.3389/fonc.2026.1815008, PubMed 42158424

Frostegård E, Bobrova T, Leinebø A, Leray T, Ghosh S, García-Hevia L, Puccinelli C, Riccio L, Sorani J, Bonifazi D, Caumartin J, Donnadieu E, Gazeau F, Hischier R, Inderberg EM, Fanarraga ML, Loustau M, Nowack B, Wälchli S, Ménard-Moyon C (2026)
Nanomedicine Meets Immunotherapy: Advancing Adoptive Cell Therapy with Nanoparticles in the Treatment of Cancer with Sustainability Perspectives
Adv Sci (Weinh), 13 (35), e22864
DOI 10.1002/advs.202522864, PubMed 41793185

Gjerde CH, Kleinmanns K, Langer A, Ruiz de Garibay Ponce G, Rozmus E, Stangeland GN, Leitch C, Elnour R, Dongre HN, Berger C, Gultekin O, Forcados C, Stensland M, Nyman TA, Lehti K, Davidson B, Wälchli S, Gelebart P, Costea DE, Kotopoulis S, Bjørge L, McCormack E (2026)
A 3D ovarian cancer metastasis model using a decellularised peritoneal matrix to study therapy response
EBioMedicine, 124, 106135
DOI 10.1016/j.ebiom.2026.106135, PubMed 41633102